SEI Investments’s Akcea Therapeutics Inc AKCA Stock Holding History

SEI Investments’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-8	Closed	–	–	3690
2018 Q2	$0	Hold	8	–	–	﹤0.01%	3891
2018 Q1	$0	Hold	8	–	–	﹤0.01%	3762
2017 Q4	$0	Buy	+8	New	+$157	﹤0.01%	3580

Other funds holding AKCA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SEI Investments's AKCA Position: Q3 2018 in Review

SEI Investments sold out of Akcea Therapeutics Inc (AKCA) in Q3 2018, closing a stake of 8 shares.

SEI Investments first reported a position in AKCA in Q4 2017 and held it in 3 quarters. The position peaked at $0 in Q2 2018. 65 funds tracked by Wall St. Rank hold AKCA as of Q3 2018.

SEI Investments reported no remaining Akcea Therapeutics Inc position as of Q3 2018 after selling out during the quarter.
SEI Investments sold 8 Akcea Therapeutics Inc shares in Q3 2018.
SEI Investments first reported a position in Akcea Therapeutics Inc in Q4 2017 and held it in 3 quarters.
SEI Investments's Akcea Therapeutics Inc position peaked at $0 in Q2 2018.
65 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q3 2018.

Based on SEI Investments's 13F filing for Q3 2018, filed 8 Nov 2018.